TrianglePUBLICATIONS · 38843469
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Sep 10
- First author
- Ettrich TJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Ettrich TJ
- type
- Author
- name
- Modest DP
- type
- Author
- name
- Sinn M
- type
- Author
- name
- Striefler JK
- type
- Author
- name
- Opitz B
- type
- Author
- name
- Goetze T
- type
- Author
- name
- Gallmeier E
- type
- Author
- name
- Angermeier S
- type
- Author
- name
- Fischer von Weikersthal L
- type
- Author
- name
- Jacobasch L
- type
- Author
- name
- Waldschmidt D
- type
- Author
- name
- Niedermeier M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ettrich TJ
- type
- Author
- name
- Modest DP
- type
- Author
- name
- Sinn M
- type
- Author
- name
- Striefler JK
- type
- Author
- name
- Opitz B
- type
- Author
- name
- Goetze T
- type
- Author
- name
- Gallmeier E
- type
- Author
- name
- Angermeier S
- type
- Author
- name
- Fischer von Weikersthal L
- type
- Author
- name
- Jacobasch L
- type
- Author
- name
- Waldschmidt D
- type
- Author
- name
- Niedermeier M
- type
- Author
- bibliography ids
- nci-bib-946ddc6984746cb7bb78fd9f
- book metadata
- content sha256
- 63881393844dce6430a2d528b2ec789c9e9a3ffaa782ac02dc1181cc4c607152
- document type
- citation
- dois
- 10.1200/JCO.23.01566
- electronic publication date
- display
- 2024 Jun 6
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38843469
- immutable id
- pubmed:38843469@63881393844dce6430a2d528b2ec789c9e9a3ffaa782ac02dc1181cc4c607152
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 26
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3094-3104
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38843469
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- d0f22e0e3ff9fc36c2c75dc13d7e2d057b91ffdc820b1a92b43991ef61f09dce
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2024 Sep 10
- precision
- day
- year
- 2024
- publication types
- Journal Article
- Clinical Trial, Phase II
- Randomized Controlled Trial
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315).
Preserved source evidence · Not medical advice